DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

0090-9556/03/3106-714-717$20.00
DMD 31:714-717, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walter, R.
Right arrow Articles by Siegmund, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walter, R.
Right arrow Articles by Siegmund, W.

INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS

R. Walter, C. Ullmann, D. Thümmler, and W. Siegmund

Department of Clinical Pharmacology of the Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, University of Greifswald, Greifswald (R.W., C.U., W.S.); and Apogepha Arzneimittel GmbH, Dresden, Germany (D.T.)

The bladder spasmolytics propiverine was shown to induce hepatic cytochrome P450 (P450) and aminopyrine and aniline oxidation in rats. To characterize the type of enzyme induction and its dose dependence, activities of seven hepatic microsomal P450-dependent monooxygenases were measured in 72 male LEW1A albino rats (body weight 236–295 g) after oral treatment with 0.5, 2, 6, and 60 mg/kg of propiverine hydrochloride for 5 days and compared with the effects of 40 mg/kg ß-naphthoflavone, 10 mg/kg phenobarbital, and 20 mg/kg dexamethasone (each group, n = 8). CYP2B expression was measured by Western blotting. Furthermore, the inhibitory potency of propiverine on P450 enzymes was evaluated in competition assays with three most specific monooxygenases. Results show that Propiverine induced several monooxygenases and CYP2B expression dose dependently. The effects were well comparable with a phenobarbital-type inducer with 60 mg/kg being equipotent to 10 mg/kg phenobarbital. Furthermore, propiverine in low concentrations inhibited pentylresorufin O-dealkylase (for CYP2B) in vitro. In conclusion, propiverine is a phenobarbital-type inducer on hepatic P450 enzymes in rats in doses about 100-times above the therapeutic doses in man.

Address correspondence to: Dr. Werner Siegmund, Department of Clinical Pharmacology, Ernst Moritz Arndt University, Friedrich Loefflerstr. 23 d, D-17487 Greifswald, Germany. E-mail: siegmuw{at}uni-greifswald.de




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
K. Methling, P. Reszka, M. Lalk, O. Vrana, E. Scheuch, W. Siegmund, B. Terhaag, and P. J. Bednarski
Investigation of the in Vitro Metabolism of the Analgesic Flupirtine
Drug Metab. Dispos., March 1, 2009; 37(3): 479 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sorgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, et al.
EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
Drug Metab. Dispos., December 1, 2005; 33(12): 1859 - 1866.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.